Simple blood test may predict Parkinson's progression

NCT ID NCT07163156

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Çanakkale Onsekiz Mart University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at whether prolactin (a hormone) and certain inflammation markers in the blood are linked to how severe Parkinson's disease is. Researchers will measure these in 300 people with Parkinson's and compare them to standard disease severity scores. The goal is to find simple, non-invasive ways to monitor the disease over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could point toward simple blood or saliva tests to help monitor Parkinson's progression.
What could go wrong: This is an early observational study, not a treatment trial. It may find no clear link, and results may not apply to all Parkinson's patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDIOPATHIC PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperprolactinemia Inflammation inflammatory disease Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IDIOPATHIC PARKINSON DISEASE INFLAMMATION PROLACTIN PROLACTIN LEVELS

Contacts and locations

Locations

Çanakkale Onsekiz Mart University

Çanakkale, Merkez, 17020, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.